10x Genomics, Inc.
TXG
$61.65
$1.672.78%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 151.04M | 150.84M | 166.03M | 149.00M | 172.91M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 151.04M | 150.84M | 166.03M | 149.00M | 172.91M |
| Cost of Revenue | 38.54M | 44.67M | 52.89M | 48.70M | 47.82M |
| Gross Profit | 112.50M | 106.18M | 113.15M | 100.31M | 125.08M |
| SG&A Expenses | 78.66M | 66.38M | 73.02M | 74.66M | 74.43M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 173.99M | 167.89M | 181.67M | 180.54M | 183.48M |
| Operating Income | -22.96M | -17.05M | -15.64M | -31.54M | -10.57M |
| Income Before Tax | -18.65M | -12.85M | -15.19M | -28.21M | 37.00M |
| Income Tax Expenses | -714.00K | 623.00K | 1.06M | -733.00K | 2.46M |
| Earnings from Continuing Operations | -17.93M | -13.47M | -16.25M | -27.47M | 34.54M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -17.93M | -13.47M | -16.25M | -27.47M | 34.54M |
| EBIT | -22.96M | -17.05M | -15.64M | -31.54M | -10.57M |
| EBITDA | -13.29M | -7.09M | -5.58M | -21.25M | -2.76M |
| EPS Basic | -0.14 | -0.11 | -0.13 | -0.22 | 0.28 |
| Normalized Basic EPS | -0.11 | -0.06 | -0.06 | -0.13 | -0.02 |
| EPS Diluted | -0.14 | -0.11 | -0.13 | -0.22 | 0.28 |
| Normalized Diluted EPS | -0.11 | -0.06 | -0.06 | -0.13 | -0.02 |
| Average Basic Shares Outstanding | 129.98M | 128.29M | 127.08M | 125.50M | 123.76M |
| Average Diluted Shares Outstanding | 129.98M | 128.29M | 127.08M | 125.50M | 124.51M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |